Department for Psychotherapy and Biopsychosocial Health, Danube University Krems, Krems, Austria.
Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Psychother Res. 2021 Nov;31(8):1012-1021. doi: 10.1080/10503307.2021.1882711. Epub 2021 Feb 8.
The aim of this study was to identify and explore mediators of psychodynamic-interpersonal psychotherapy (PIT) on treatment outcome in multisomatoform disorders (MSD). Data from 164 patients with MSD who took part in a randomized control trial of PIT (= 88) vs. enhanced medical care (EMC; = 76) were re-analyzed. A parallel mediation analysis was performed to investigate whether the beneficial effect of PIT vs. EMC on physical quality of life (physical component summary (PCS) of the SF-36 Health Survey) nine months post-treatment is mediated by post-treatment scores of stress, depression, and therapeutic alliance. The potential mediators were operationalized with the Helping Alliance Questionnaire (HAQ; therapeutic alliance), the Patient Health Questionnaire (PHQ)-stress module (perceived stress) and the PHQ-depression module (PHQ-9; depression). Stress partially mediated the effect of PIT vs. EMC on the follow-up outcome. PIT (as compared to EMC) led to lower post-treatment stress-levels, which in turn led to higher physical quality of life at follow-up. Neither depression nor the alliance had a mediating effect. Stress mediated the outcome of PIT for MSD. Future studies are needed to extend the scope of research regarding which specific psychotherapeutic mechanisms of change are beneficial in PIT treatment of MSD patients.
本研究旨在确定和探讨精神动力-人际心理治疗(PIT)对躯体形式障碍(MSD)治疗结果的中介因素。对 164 名接受 PIT(n=88)与增强医疗护理(EMC;n=76)的随机对照试验的 MSD 患者的数据进行了重新分析。进行了平行中介分析,以探讨治疗后 9 个月,PIT 与 EMC 对生理生活质量(SF-36 健康调查的生理成分综合评分(PCS))的有益影响是否通过治疗后压力、抑郁和治疗联盟的评分来中介。潜在的中介变量是通过帮助联盟问卷(HAQ;治疗联盟)、患者健康问卷(PHQ-压力模块)和 PHQ-抑郁模块(PHQ-9;抑郁)来实现的。压力部分中介了 PIT 与 EMC 对随访结果的影响。与 EMC 相比,PIT 导致治疗后压力水平降低,进而导致随访时的生理生活质量更高。抑郁和联盟都没有中介作用。压力中介了 PIT 对 MSD 的治疗结果。需要进一步的研究来扩展关于哪些特定的心理治疗变化机制对 PIT 治疗 MSD 患者有益的研究范围。